Health Level Seven® International (HL7®) International have announced an agreement to create a complementary process to foster interoperability that will lead to improvements in patient safety.
As part of the new agreement, both organisations will create a consistent industry-wide process and mechanism for pathology specimen identification and labeling that will streamline the process of reporting clinical information.
The object is to allow integrated workflows across all systems and users in specimen handling and processing. In addition to the three HL7 Work Groups, this project will also involve the CLSI, College of American Pathologists, GS1, a not-for-profit organisation that designs and manages a global system of supply chain standards, and IHE Anatomic Pathology.
HL7 and CLSI (formerly known as NCCLS) have a long history of cooperation, which has yielded results such as the development of an HL7 laboratory automation chapter by CLSI for HL7s Version 2 Standard. CLSI also created a table that became part of HL7s table for abnormal flags.
This continued partnership between CLSI and HL7 brings together the knowledge and skills to benefit the health care community, said Ken McCaslin, HL7 Fellow, co-chair of HL7s Orders/Observations Work Group, and co-chair of HL7s Technical and Support Services Steering Division. CLSIs evolving standards to improve the laboratory industry and HL7s leadership in the development of standards in clinical and administrative data is the perfect combination of scientific knowledge with information technology.
Glen Fine, MS, MBA, CAE, utive Vice President of CLSI, added, I am delighted that both organizations can maximize our complementary missions and member talents once again, and work jointly to improve the quality of patient care.
CLSI is a worldwide leader in developing voluntary consensus standards and guidelines in medical testing practices and health care, and is committed to facilitating global harmonization and development of medical testing standards and guidelines worldwide. The organisation promotes the development, uation, approval, and implementation of international national standards for health care services, medical testing, and clinical and other laboratory services in order to maintain and improve public health, and its collaboration with HL7 aligns with this mission.